移植肾组织中补体C4d沉积在CAN的诊断和治疗中的临床意义  

Retrospective study of the effect of C4d deposition in peritubular capillary in chronic allograft nephropathy on the prognosis of renal allografts

作　　者：李民[1] 刘永光[1] 蔡瑞明[1] 郭颖[1] 赵明[1] 

机构地区：[1]南方医科大学珠江医院器官移植科,广州510282

出　　处：《中华器官移植杂志》2010年第11期651-653,共3页Chinese Journal of Organ Transplantation

基　　金：基金项目：广东省自然科学基金资助（06024438）

摘　　要：目的 探讨移植肾组织中补体C4d沉积在慢性移植肾肾病（CAN）的诊断和治疗中的临床意义.方法 将2000年1月至2008年8月间诊断为CAN,且已行移植肾活检,并能收集到活检后2年以上随访资料者纳入研究.符合标准者共有86例,其中男性53例,女性33例,移植时年龄18～65岁.应用免疫组织化学染色方法检测移植肾组织活检标本C4d的表达.所有患者在行移植肾穿刺诊断为CAN后均给予了常规治疗.结果 86例患者中,C4d沉积阳性者（C4d阳性组）39例,C4d沉积阴性者（C4d阴性组）47例,两组患者在性别、年龄、供肾来源、多次移植、移植时群体反应性抗体水平等各指标的比较,差异均无统计学意义（P＞0.05）.活检2年后,C4d阳性组和阴性组患者的SCr水平分别为（551.5±140.4）和（443.0±133.1）μmol/L,两组比较,差异有统计学意义（P＜0.05）;并且C4d阳性组患者移植肾功能丧失率（23.1%,10/39）也显著高于C4d阴性组（8.5%,4/47）,两组比较,差异有统计学意义（P＜0.05）.CAN治疗前,C4d阳性组发生高血压和高血脂者多于阴性组（P＜0.05）;常规治疗后,剔除移植肾功能丧失者,两组间发生高血压、高血脂、高血糖和高血尿酸者差异无统计学意义（P＞0.05）.结论 C4d阳性的CAN患者提示有慢性体液排斥反应的参与,临床常规治疗预后较差,若针对体液免疫反应进行干预,能够改善移植肾长期存活.Objective To investigate the effect of C4d deposition in peritubular capillary （PTC）in chronic allograft nephropathy （CAN） on prognosis and intervention of renal transplantation recipients. Methods All the cases who received the renal graft biopsy due to diagnosis of CAN from January 2000 to August 2008, and had the 2-year follow-up data were included in the study. The clinical data were analyzed according to the C4d deposition in PTC. Results Among 86 cases 39 cases were C4d positive （C4d＋ group） and the remaining 47 cases were negative （C4d group）. There was no significant difference in sex, age, donor source, transplant times, time after biopsy, the panel reactive antibodies （PRA） level between two groups （P〉0. 05）. Before intervention, there was no significant difference in serum creatinine （Scr） and 24 h urinary protein between two groups （P〉0. 05）. At the end of 2-year followed-up period, graft loss rate and urinary protein levels in C4d＋group were significantly higher than in C4d- group （P〈0. 05）. Before intervention, the incidence of blood lipid disorder and hypertension was higher in C4d- group （P 〈 0. 05 ）, but no significant difference was found in uric acid and blood sugar levels （P〉0. 05）. At the end of 2-year followed-up period, there was no significant difference in blood glucose, uric acid, blood pressure and lipid profile （eliminating renal lost cases） between two groups （P〉0. 05）. Conclusion The patients with CAN and C4d＋ means the involvement of chronic humoral rejection and have poor clinical results. Effective intervention against humoral immune response can improve renal allograft survival.

关 键 词：肾移植 补体C4d 慢性移植肾肾病 免疫 体液 

分 类 号：R686[医药卫生—骨科学]